29/01/2025 – AB Science provides a summary of the webcast held on January 28, 2025 Download PDF Post navigationPreviousPrevious post:AB Science webcast of January 28, 2025NextNext post:Article from the leading publication Life Sciences Magazine featuring AB Science’s masitinib and its Phase 3 principal investigator, the neurologist Patrick VermerschRelated PostsArticle from the leading publication Life Sciences Magazine featuring AB Science’s masitinib and its Phase 3 principal investigator, the neurologist Patrick VermerschMarch 4, 2025AB Science webcast of January 28, 2025January 29, 2025Live webcast on Tuesday January 28, 2025, from 5.30pm to 6.45pm CETJanuary 24, 2025AB Science will participate in the Biomed Forum investors conferenceJanuary 22, 2025Summary of the webcast held on December 16, 2024December 17, 2024AB Science webcast of December 16, 2024December 16, 2024
Article from the leading publication Life Sciences Magazine featuring AB Science’s masitinib and its Phase 3 principal investigator, the neurologist Patrick VermerschMarch 4, 2025
